DE2150279C2 - Blutzuckersenkende Sulfamoylpyrimidine mit asymmetrischem Kohlenstoffatom - Google Patents

Blutzuckersenkende Sulfamoylpyrimidine mit asymmetrischem Kohlenstoffatom

Info

Publication number
DE2150279C2
DE2150279C2 DE2150279A DE2150279A DE2150279C2 DE 2150279 C2 DE2150279 C2 DE 2150279C2 DE 2150279 A DE2150279 A DE 2150279A DE 2150279 A DE2150279 A DE 2150279A DE 2150279 C2 DE2150279 C2 DE 2150279C2
Authority
DE
Germany
Prior art keywords
phenylacetic acid
pyrimidinyl
sulfamoyl
blood sugar
sulfamoylpyrimidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2150279A
Other languages
German (de)
English (en)
Other versions
DE2150279A1 (de
Inventor
Hanns Dr. Ahrens
Helmut Dr. Biere
Erich Dr.Dr. Gerhards
Olaf Dr. Loge
Wolfgang Dr. Losert
Clemens Dr. Rufer
Ekkehard Dr. 1000 Berlin Schillinger
Eberhard Dr. Schröder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE789712D priority Critical patent/BE789712R/xx
Application filed by Schering AG filed Critical Schering AG
Priority to DE2150279A priority patent/DE2150279C2/de
Priority to NO713870A priority patent/NO133138C/no
Priority to DK515571A priority patent/DK136034C/da
Priority to SE7113647A priority patent/SE385213B/xx
Priority to CH1193572A priority patent/CH568982A5/xx
Priority to US288590A priority patent/US3878213A/en
Priority to DD165981A priority patent/DD103442A6/xx
Priority to AT846672A priority patent/AT319952B/de
Priority to AU47356/72A priority patent/AU483774B2/en
Priority to FR7235168A priority patent/FR2158207A2/fr
Priority to NL7213535A priority patent/NL7213535A/xx
Priority to JP47100227A priority patent/JPS4844272A/ja
Priority to ZA727126A priority patent/ZA727126B/xx
Priority to CA153,350A priority patent/CA977755A/en
Priority to GB4604672A priority patent/GB1403264A/en
Priority to IL40514A priority patent/IL40514A/en
Publication of DE2150279A1 publication Critical patent/DE2150279A1/de
Application granted granted Critical
Publication of DE2150279C2 publication Critical patent/DE2150279C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
DE2150279A 1970-04-28 1971-10-05 Blutzuckersenkende Sulfamoylpyrimidine mit asymmetrischem Kohlenstoffatom Expired DE2150279C2 (de)

Priority Applications (17)

Application Number Priority Date Filing Date Title
BE789712D BE789712R (fr) 1970-04-28 Sulfamoylpyrimidines, a atome de carbone asymetrique, leur procede de preparation et leur
DE2150279A DE2150279C2 (de) 1971-10-05 1971-10-05 Blutzuckersenkende Sulfamoylpyrimidine mit asymmetrischem Kohlenstoffatom
NO713870A NO133138C (enExample) 1971-10-05 1971-10-19
DK515571A DK136034C (da) 1971-10-05 1971-10-22 Analogifremgangsmade til fremstilling af sulfamoylpyrimidiner
SE7113647A SE385213B (sv) 1971-10-05 1971-10-27 Sett att framstella blodsockersenkande sulfamoylpyrimidiner med asymmetrisk kolatom
CH1193572A CH568982A5 (enExample) 1971-10-05 1972-08-11
US288590A US3878213A (en) 1971-03-31 1972-09-13 Certain 4-(n-pyrimidin-2-ylsulfamoyl)-phenylacetamides
DD165981A DD103442A6 (enExample) 1971-10-05 1972-10-02
AT846672A AT319952B (de) 1971-10-05 1972-10-03 Verfahren zur Herstellung neuer Sulfamoylpyrimidine und ihrer Salze
AU47356/72A AU483774B2 (en) 1971-10-05 1972-10-04 Sulphamoyl-pyrimidines containing an asymmetric 1 carbon atom and having a blood sugar lowering activity
FR7235168A FR2158207A2 (en) 1970-04-28 1972-10-04 Sulphamoyl pyrimidines contg asymmetric carbon atoms
NL7213535A NL7213535A (enExample) 1971-10-05 1972-10-05
JP47100227A JPS4844272A (enExample) 1971-10-05 1972-10-05
ZA727126A ZA727126B (en) 1971-10-05 1972-10-05 Sulphamoyl-pyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity
CA153,350A CA977755A (en) 1971-10-05 1972-10-05 Process for producing sulphamoyl-pyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity
GB4604672A GB1403264A (en) 1971-10-05 1972-10-05 Sulphamoyl-pyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity
IL40514A IL40514A (en) 1971-10-05 1972-10-05 Sulphamoyl-pyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2150279A DE2150279C2 (de) 1971-10-05 1971-10-05 Blutzuckersenkende Sulfamoylpyrimidine mit asymmetrischem Kohlenstoffatom

Publications (2)

Publication Number Publication Date
DE2150279A1 DE2150279A1 (de) 1973-04-12
DE2150279C2 true DE2150279C2 (de) 1983-08-25

Family

ID=5821847

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2150279A Expired DE2150279C2 (de) 1970-04-28 1971-10-05 Blutzuckersenkende Sulfamoylpyrimidine mit asymmetrischem Kohlenstoffatom

Country Status (13)

Country Link
JP (1) JPS4844272A (enExample)
AT (1) AT319952B (enExample)
CA (1) CA977755A (enExample)
CH (1) CH568982A5 (enExample)
DD (1) DD103442A6 (enExample)
DE (1) DE2150279C2 (enExample)
DK (1) DK136034C (enExample)
GB (1) GB1403264A (enExample)
IL (1) IL40514A (enExample)
NL (1) NL7213535A (enExample)
NO (1) NO133138C (enExample)
SE (1) SE385213B (enExample)
ZA (1) ZA727126B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119077A1 (de) * 1981-05-14 1982-12-02 Basf Ag, 6700 Ludwigshafen Heterocyclische dihalogenacetmide, verfahren zu ihrer herstellung und herbizide mittel, die acetanilide als herbizide wirkstoffe und diese dihalogenacetamine als antagonistische mittel enthalten
BRPI0710487A2 (pt) 2006-04-12 2012-06-05 Merck & Co Inc composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitácel do mesmo e, método para tratar ou controlar a epilepsia e a dor e para o tratamento ou prevenção de um distúrbio do sono em um paciente.
KR20100072266A (ko) 2007-10-24 2010-06-30 머크 샤프 앤드 돔 코포레이션 헤테로사이클 페닐 아미드 ｔ-형 칼슘 채널 길항제
TW201625588A (zh) * 2014-11-05 2016-07-16 第一三共股份有限公司 環狀胺衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695855C3 (de) * 1967-12-30 1979-07-12 Schering Ag, 1000 Berlin Und 4619 Bergkamen 4-(5-Isobutyl-2-pyrimidinyl)-sulfonamidophenylessigsäure-(2-methoxy-5chloranilid) und dessen Salze mit physiologisch verträglichen Basen
JPS5516143A (en) * 1978-07-18 1980-02-04 Yoshihisa Horikoshi Spindle

Also Published As

Publication number Publication date
CA977755A (en) 1975-11-11
ZA727126B (en) 1973-06-27
AU4735672A (en) 1974-04-11
JPS4844272A (enExample) 1973-06-26
DK136034C (da) 1978-01-23
AT319952B (de) 1975-01-27
CH568982A5 (enExample) 1975-11-14
IL40514A0 (en) 1972-12-29
IL40514A (en) 1976-12-31
NO133138C (enExample) 1976-03-17
SE385213B (sv) 1976-06-14
DD103442A6 (enExample) 1974-01-20
DK136034B (da) 1977-08-01
GB1403264A (en) 1975-08-28
NL7213535A (enExample) 1973-04-09
DE2150279A1 (de) 1973-04-12
NO133138B (enExample) 1975-12-08

Similar Documents

Publication Publication Date Title
AT363096B (de) Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen
DE2528360A1 (de) Neue pyrimidine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
CH641159A5 (de) Verfahren zur herstellung von neuen guanidinderivaten.
EP0028765B1 (de) Alkylharnstoffderivate zur Behandlung von Erkrankungen des Fettstoffwechsels; Verfahren zu deren Herstellung, deren Verwendung in Arzneimitteln zur Behandlung von Fettstoffwechselstörungen, diese enthaltende Arzneimittel, Verfahren zur Herstellung der Arzneimittel sowie einige Alkylharnstoffverbindungen
DE2012138B2 (de) N-eckige klammer auf 4-(beta-pyrazin- 2-carboxyamido-aethyl)-benzolsulphonyl eckige klammer zu -n' - cycloalkylharnstoffe und diese enthaltende pharmazeutische praeparate
DE1695677B1 (de) N-Arylsulfonyl-N'-(3-aza-bicycloalkyl)-harnstoffe,ihre Salze und Verfahren zu ihrer Herstellung
EP0030650A1 (de) 1-Piperidinsulfonylharnstoffe, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung
DE2446758C3 (de) 2-(2-Fluor-6-trifluormethylphenylimino)-imidazolidin, dessen Säureadditionssalze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung der Hypertonie
DE2150279C2 (de) Blutzuckersenkende Sulfamoylpyrimidine mit asymmetrischem Kohlenstoffatom
EP0132811A1 (de) In 1-Stellung substituierte 4-Hydroxymethyl-pyrrolidinone, Verfahren zu ihrer Herstellung, pharmazeutische Zusammensetzungen und Zwischenprodukte
DE1940566C3 (de) 1- (2-Nitrilophenoxy)-2-hydroxy-3äthylaminopropan, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
DE2711225C2 (enExample)
EP1317430B1 (de) (2-azabicyclo [2.2.1]hept-7-yl)methanol-derivate als nikotinische acetylcholinrezeptor agonisten
CH628887A5 (de) Verfahren zur herstellung von benzolsulfonylharnstoffen.
DE1543564A1 (de) Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE1518816C3 (de) Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
EP0313935A2 (de) Enolether von 6-Chlor-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carbonsäureamid-1,1-dioxid, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
DE2636866A1 (de) Neue phenothiazinderivate und deren herstellung
CH474490A (de) Verfahren zur Herstellung neuer Benzolsulfonylharnstoffe
DE2004301A1 (de) Phenylserinderivate
DE2027950A1 (de) Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE2833073A1 (de) Thioharnstoffderivate, verfahren zu ihrer herstellung, verwendung derselben und diese enthaltende arzneimittel
DE2423725A1 (de) 5-phenyl-4-oxo-delta hoch 2,alphathiazolidinessigsaeureester
DE2031360A1 (de) Neue cyclische Verbindungen und Ver fahren zu ihrer Herstellung
DE1443908C3 (de) Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel

Legal Events

Date Code Title Description
8126 Change of the secondary classification

Free format text: C07D401/12 A61K 31/505

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee